Patents by Inventor Alain Matagne

Alain Matagne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for Enhancing the Cognitive Function
    Publication number: 20120171125
    Abstract: A compound having an affinity to a SV2 protein for the treatment of a condition associated with enhancement or improvement of the cognitive ability or to counteract cognitive decline of a mammal. For example, a compound which is covered by formula (I) R1 is an halogen atom, preferably, a chlorine or a fluorine atom; n is equal to 1, 2 or 3; and R2 is cyano.
    Type: Application
    Filed: August 4, 2010
    Publication date: July 5, 2012
    Applicant: UCB PHARMA, S.A.
    Inventors: Benoît Kenda, Alain Matagne
  • 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
    Patent number: 8034958
    Abstract: The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.
    Type: Grant
    Filed: February 17, 2010
    Date of Patent: October 11, 2011
    Assignee: UOB Pharma, S.A.
    Inventors: Edmond Differding, Benoît Kenda, Bénédicte Lallemand, Alain Matagne, Philippe Michel, Patrick Pasau, Patrice Talaga
  • 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
    Publication number: 20100222576
    Abstract: The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.
    Type: Application
    Filed: February 17, 2010
    Publication date: September 2, 2010
    Inventors: Edmond Differding, Benoît Kenda, Bénédicte Lallemand, Alain Matagne, Philippe Michel, Patrick Pasau, Patrice Talaga
  • 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
    Patent number: 7692028
    Abstract: The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.
    Type: Grant
    Filed: December 13, 2007
    Date of Patent: April 6, 2010
    Assignee: UCB Pharma, S.A.
    Inventors: Edmond Differding, Benoît Kenda, Bénédicte Lallemand, Alain Matagne, Philippe Michel, Patrick Pasau, Patrice Talaga
  • 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
    Publication number: 20080097109
    Abstract: The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.
    Type: Application
    Filed: December 13, 2007
    Publication date: April 24, 2008
    Inventors: Edmon Differding, Benoit Kenda, Benedicte Lallemand, Alain Matagne, Philippe Michel, Patrick Pasau, Patrick Talaga
  • 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
    Patent number: 7358276
    Abstract: The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: April 15, 2008
    Assignee: UCB, S.A.
    Inventors: Edmond Differding, Benoît Kenda, Bénédicte Lallemand, Alain Matagne, Philippe Michel, Patrick Pasau, Patrice Talaga
  • Pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders
    Publication number: 20050187205
    Abstract: A use of (S)-(?)-?-ethyl-2-oxo-1-pyrrolidineacetamide for the manufacture of a medicament for treatment of particular diseases and new pharmaceutical compositions comprising (S)-(?)-?-ethyl-2-oxo-1-pyrrolidineacetamtide.
    Type: Application
    Filed: April 21, 2005
    Publication date: August 25, 2005
    Inventors: Yves Lamberty, Alain Matagne, Henrik Klitgaard, Tony Waegemans
  • 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
    Publication number: 20050171187
    Abstract: The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.
    Type: Application
    Filed: January 27, 2005
    Publication date: August 4, 2005
    Inventors: Edmond Differding, Benoit Kenda, Benedicte Lallemand, Alain Matagne, Philippe Michel, Patrick Pasau, Patrice Talaga
  • 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
    Publication number: 20050171188
    Abstract: The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.
    Type: Application
    Filed: January 27, 2005
    Publication date: August 4, 2005
    Inventors: Edmond Differding, Benoit Kenda, Benedicte Lallemand, Alain Matagne, Philippe Michel, Patrick Pasau, Patrice Talaga
  • 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
    Patent number: 6911461
    Abstract: The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.
    Type: Grant
    Filed: October 28, 2003
    Date of Patent: June 28, 2005
    Assignee: UCB, S.A.
    Inventors: Edmond Differding, Benoît Kenda, Bénédicte Lallemand, Alain Matagne, Philippe Michel, Patrick Pasau, Patrice Talaga
  • Pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
    Patent number: 6903130
    Abstract: A use of (S)-(?)-?-ethyl-2-oxo-1-pyrrolidineacetamide for the manufacture of a medicament for treatment of particular disease and new pharmaceutical compositions comprising (S)-(?)-?-ethyl-2-oxo-1-pyrrolidineacetamide.
    Type: Grant
    Filed: November 27, 2000
    Date of Patent: June 7, 2005
    Assignee: UCB S.A.
    Inventors: Yves Lamberty, Alain Matagne, Henrik Klitgaard, Tony Waegemans
  • 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
    Patent number: 6806287
    Abstract: The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.
    Type: Grant
    Filed: October 28, 2003
    Date of Patent: October 19, 2004
    Assignee: UCB, S.A.
    Inventors: Edmond Differding, Benoît Kenda, Bénédicte Lallemand, Alain Matagne, Philippe Michel, Patrick Pasau, Patrice Talaga
  • 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
    Patent number: 6784197
    Abstract: The invention concerns 2-oxo-1-pyrrolidine derivatives of formula (I) wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.
    Type: Grant
    Filed: August 20, 2002
    Date of Patent: August 31, 2004
    Assignee: UCB S.A.
    Inventors: Edmond Differding, Benoît Kenda, Bénédicte Lallemand, Alain Matagne, Philippe Michel, Patrick Pasau, Patrice Talaga
  • 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
    Publication number: 20040116507
    Abstract: The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, 1
    Type: Application
    Filed: October 28, 2003
    Publication date: June 17, 2004
    Inventors: Edmond Differding, Benoit Kenda, Benedicte Lallemand, Alain Matagne, Philippe Michel, Patrick Pasau, Patrice Talaga
  • 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
    Publication number: 20040087646
    Abstract: The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, 1
    Type: Application
    Filed: October 28, 2003
    Publication date: May 6, 2004
    Inventors: Edmond Differding, Benoit Kenda, Benedicte Lallemand, Alain Matagne, Philippe Michel, Patrick Pasau, Patrice Talaga
  • 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
    Publication number: 20030120080
    Abstract: The invention concerns 2-oxo-1-pyrrolidine derivatives of formula (I) wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.
    Type: Application
    Filed: August 20, 2002
    Publication date: June 26, 2003
    Inventors: Edmond Differding, Benoit Kenda, Benedicte Lallemand, Alain Matagne, Philippe Michel, Patrick Pasau, Patrice Talaga